Mohamed Khairie Issa, EVP, Head of US Oncology at INCYTE CORP (INCY), sold 19,120 shares at $109.07 ($2.1M) on 2026-01-07, disclosed to the SEC on 2026-01-08.
Open-market sale of $2.1M INCY by EVP, Head of US Oncology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $106.66 | 8,264 | $881K | 42.7% |
| 2 | $109.07 | 10,856 | $1.2M | 57.3% |
| Total | $108.03 avg | 19,120 | $2.1M | 100% |